This message was sent to ##Email##
|
|
|
|
|
| |
AST
We just launched the 2017 COP giving contest: The Donation Derby. Watch this race, as the COPs compete for two prizes. All donations made by COPs until the end of the year will count towards this contest, so be sure to check it out today.
READ MORE
AST
Nominations for AST Awards are closing November 17. We encourage you to consider nominating deserving candidates for one of ten Achievement Awards and for our new Innovation Award. Each have their own eligibility, available on our website.
AST
The Fellow of the American Society of Transplantation (FAST) designation application is now open to all members who meet the eligibility criteria. Instructions for the application can be found here. The deadline to apply is January 15, 2018. Don’t miss out on joining this prestigious program and being recognized for your contributions to transplantation.
READ MORE
 |
|
We are collaborating with the transplant community to improve the health of transplant patients through
• Innovative approaches and partnerships in data generation
• Working to improve long-term graft and patient survival
• Encouraging success through patient programs and outreach
We are committed to you, your patients, and the future of transplantation
|
|
AST
On November 7, the AST- endorsed Veterans Transplant Coverage Act passed in the House of Representatives. The AST supported this important legislation and pushed for the final passage of the bill. Read more about this bill on the AST website.
In related news, the VICTOR Act of 2017 also passed in the House of Representatives. Read more about this bill here.
AST
Visit the AST Member Spotlight page to find out how a fortune teller predicted one aspect of Dr. Gilles Benichou's work in transplantation many years ago.
Interested in being featured in the AST Member Spotlight? Please contact rpaulin@myast.org for more information.
 |
|
A blood test that measures donor-derived cell-free DNA, a direct indicator of kidney injury
Ideal rejection surveillance tool with high NPV and specificity
Clinically and analytically validated
Covered by Medicare
Learn more at www.allosure.com
|
|
AST
As part of our Power2Save awareness campaign, we have partnered with Organize and Tribute to create an opportunity for the transplant community to share their stories through short videos. All organ transplant recipients, living donors, caregivers, advocates, medical professionals, and registered organ donors are welcome to participate. Our goal is to raise the funds required to establish a research grant, so please consider making a donation today.
READ MORE
AST
The AST is now accepting nominations for the 2018 Board Elections. Open positions on the Board of Directors include President-Elect, Treasurer (two-year term), and three Councilors-at-Large (three-year terms). The term of service begins with the rotation of the Board at the Town Hall that will be held during the 2018 American Transplant Congress in Seattle, WA.
READ MORE
|
|
|
|
|
| |
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. The AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
AST
The Comprehensive Trainee Curriculum (CTC) is AST's latest addition to its member benefits. This feature is an online educational platform that features dozens of webinars on various concentrations of transplantation.
READ MORE
AST
November 14, 2017 2 p.m. Online Activity
For more information, click here.
AST
"Zbtb7a Induction in Alveolar Macrophages is Implicated in Anti-HLA–Mediated Lung Allograft Rejection"
November 20, 2017 | 12 p.m. ET | Online activity
For more information: https://www.myast.org/education/astajt-journal-club
"THE NATIONAL LANDSCAPE OF LIVING KIDNEY DONOR FOLLOW-UP IN THE UNITED STATES"
December 7, 2017 | 2 p.m. ET | Online activity
For more information: https://www.myast.org/education/astajt-journal-club
AST
The Transplant Nephrology Core Curriculum (TNCC) is an online program jointly provided by the American Society of Nephrology and the American Society of Transplantation. The TNCC focuses on key information needed to prepare for the American Board of Internal Medicine Nephrology Board Certification and Maintenance of Certification examinations.
READ MORE
AST
Join us in sunny Phoenix, AZ at the beautiful Biltmore Hotel, February 8-10, 2018 for this exciting meeting! This year's topic will focus on breaking through regulatory barriers to unleash the innovation needed to advance the field of transplantation!
READ MORE
AST
Submitting an abstract to the American Transplant Congress means that it will be peer reviewed and may be accepted for either an oral or a poster presentation. All accepted abstracts will be published in an online Supplement to The American Journal of Transplantation (AJT), the Joint Jounal of the American Society of Transplant Surgeons (ASTS) and American Society of Transplantation (AST).
READ MORE
JAMA Oncology
Several factors are associated with increased hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT), but no reliable risk score has been established to determine the individual risk for HCC recurrence. This study aimed to develop and validate a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) score for patients with HCC meeting Milan criteria by imaging.
READ MORE
Annals of Surgery
The Milan criteria are used to allocate livers to patients with HCC requiring liver transplantation (LT) but do not include objective measures of tumor biology. Biological markers including the neutrophil-lymphocyte ratio (NLR) and alpha-fetoprotein (AFP) have been associated with recurrence risk. This study sought to develop a “Model Of Recurrence After Liver transplant” (MORAL) for hepatocellular carcinoma (HCC).
READ MORE
American Journal of Transplantation
Fifty years have passed since the first human heart transplant in December 1967. Despite many advances in the science of transplantation, however, the community still lacks a solid method to assess rejection. This knowledge gap has led researchers to search for what Jon A. Kobashigawa, M.D., professor of medicine at Cedars-Sinai Medical Center in Los Angeles, describes as “a new gold standard for the detection of rejection.” The task has become more complex because, in addition to T cell–mediated rejection, a more easily missed antibody-mediated rejection exists.
READ MORE
American Journal of Transplantation
The availability of direct-acting antiviral agents for the treatment of hepatitis C virus (HCV) infection has resulted in a profound shift in the approach to the management of this infection. These changes have affected the practice of solid organ transplantation by altering the framework by which patients with end-stage organ disease are managed and receive organ transplants.
READ MORE
American Journal of Transplantation
Hepatitis C virus (HCV) infection is associated with reduced patient survival following combined liver-kidney transplantation (LKT). The aim of this study was to assess the efficacy and safety of second-generation direct-acting antivirals (DAAs) in this difficult-to-treat population. The ANRS CO23 “Compassionate use of Protease Inhibitors in Viral C Liver Transplantation” (CUPILT) study is a prospective cohort including transplant recipients with recurrent HCV infection treated with DAAs.
READ MORE
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
